What ICH Q3A(R2): Impurities in New Drug Substances requires
ICH Q3A(R2) sets reporting, identification, and qualification thresholds for organic impurities in new drug substances based on maximum daily dose…
This is a preview. The full record adds the complete summary, 8 workflow steps, 17 schema fields and 5 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: International Council for Harmonisation (ICH) · Version: 1.0.0 · Last updated:
Primary source: https://database.ich.org/sites/default/files/Q3A%28R2%29%20Guideline.pdf
SHA-256 integrity: 73ecf46f692d651ca51c376de38ab1b3f6520a8b2cad492ab91252d8fb8dd8b5
Primary Citations — 5 traced to source
- ICH Harmonised Tripartite Guideline Q3A(R2) Impurities in New Drug Substances, October 2006
- European Pharmacopoeia general Control of impurities in substances for pharmaceutical use
+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/ich-q3a-r2-impurities-new-drug-substances.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/ich-q3a-r2-impurities-new-drug-substances.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/ich-q3a-r2-impurities-new-drug-substances
- Back to registry: Browse all 10,102 compliance nodes